Thursday, May 14, 2015

Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin.

Thorax. 2015 May 11. pii: thoraxjnl-2014-206420. doi: 10.1136/thoraxjnl-2014-206420. [Epub ahead of print]
Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin.
Author information


Abstract
RATIONALE:
Respiratory tract infections are common in patients suffering from pulmonary fibrosis. The interplay between bacterial infection and fibrosis is characterised poorly.
OBJECTIVES:
To assess the effect of Gram-positive bacterial infection on fibrosis exacerbation in mice.
METHODS:
Fibrosis progression in response to Streptococcus pneumoniae was examined in two different mouse models of pulmonary fibrosis.
MEASUREMENTS AND MAIN RESULTS:
We demonstrate that wild-type mice exposed to adenoviral vector delivery of active transforming growth factor-β1 (TGFß1) or diphteria toxin (DT) treatment of transgenic mice expressing the DT receptor (DTR) under control of the surfactant protein C (SPC) promoter (SPC-DTR) to induce pulmonary fibrosis developed progressive fibrosis following infection with Spn, without exhibiting impaired lung protective immunity against Spn. Antibiotic treatment abolished infection-induced fibrosis progression. The cytotoxin pneumolysin (Ply) of Spn caused this phenomenon in a TLR4-independent manner, as Spn lacking Ply (SpnΔply) failed to trigger progressive fibrogenesis, whereas purified recombinant Ply did. Progressive fibrogenesis was also observed in AdTGFβ1-exposed Ply-challenged TLR4 KO mice. Increased apoptotic cell death of alveolar epithelial cells along with an attenuated intrapulmonary release of antifibrogenic prostaglandin E2 was found to underlie progressive fibrogenesis in Ply-challenged AdTGFβ1-exposed mice. Importantly, vaccination of mice with the non-cytotoxic Ply derivative B (PdB) substantially attenuated Ply-induced progression of lung fibrosis in AdTGFβ1-exposed mice.
CONCLUSIONS:
Our data unravel a novel mechanism by which infection with Spn through Ply release induces progression of established lung fibrosis, which can be attenuated by protein-based vaccination of mice.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
KEYWORDS:
Bacterial Infection; Idiopathic pulmonary fibrosis; Respiratory Infection

PMID: 25964315 [PubMed - as supplied by publisher]

No comments:

Post a Comment